Category
blog
-
2023
-
Merck agrees to build bioprocessing production plant in South Korea
-
Sun Pharma’s Deuruxolitinib IND Placed on Partial Clinical Hold
-
FDA Approves First-Ever RSV Vaccine
-
Vertex secures FDA clearance for infants’ cystic fibrosis therapy
-
Boehringer Ingelheim Earns Breakthrough Therapy Designation for Pustular Psoriasis Drug
-
Lupin to acquire French firm Medisol for around Rs 160 crore
-
EMA to review CTIS transparency rules
-
Cognixion receives FDA Breakthrough Device Designation for assisted communication device
-
Japan’s Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma
-
FDA warns vs fake versions of popular medicines